A tremendous number of researches indicated that high levels of PD-L1 expression was seen in a few cancers and exploited the PD-L1 and/or PD-1 signaling alternation to induce T-cell-mediated immune escape [61]. This evidence concerns the gene PDCD1 and cancer.